Pharmacies versus doctors' offices for adolescent vaccination.

Abstract:

PURPOSE:We sought to understand the relative advantage of pharmacies compared to doctors' offices for delivering HPV vaccination to adolescents. METHODS:Participants were a national sample of 1500 U.S. parents of adolescents ages 11-17 recruited in 2014-15. In an online survey, items informed by Diffusion of Innovation Theory assessed parents' perceptions of the relative advantages of HPV vaccine delivery in pharmacies and doctors' offices. PRINCIPLE FINDINGS:Many parents believed doctor's offices offered a better health care environment than pharmacies, with more privacy (77%) and a safer place for vaccination (70%). However, many parents also believed pharmacies were more accessible than doctors' offices, requiring less time for vaccinations (71%) and offering more convenient hours (59%). Parents were more willing to get their children HPV vaccine from pharmacists if they indicated more relative advantages in vaccine delivery in pharmacies (β = .29; p < .001) and believed patient accessibility more important than health care environment (β = .20; p < .001). CONCLUSIONS:To be more appealing to parents as HPV vaccine providers, pharmacy providers within community and hospital settings should build on their relative advantage with respect to accessibility and enhance their appeal of their healthcare environment.

journal_name

Vaccine

journal_title

Vaccine

authors

Shah PD,Marciniak MW,Golden SD,Trogdon JG,Golin CE,Brewer NT

doi

10.1016/j.vaccine.2018.04.088

subject

Has Abstract

pub_date

2018-06-07 00:00:00

pages

3453-3459

issue

24

eissn

0264-410X

issn

1873-2518

pii

S0264-410X(18)30608-X

journal_volume

36

pub_type

杂志文章

相关文献

VACCINE文献大全
  • New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain.

    abstract::Both seasonal and pandemic influenza cause considerable morbidity and mortality globally. In addition, the ongoing threat of new, unpredictable influenza pandemics from emerging variant strains cannot be underestimated. Recently bioCSL (previously known as CSL Biotherapies) sponsored a symposium 'New Wisdom to Defy an...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2013.02.033

    authors: Poland GA,Fleming DM,Treanor JJ,Maraskovsky E,Luke TC,Ball EM,Poland CM

    更新日期:2013-04-17 00:00:00

  • Assessment of preparation time with fully-liquid versus non-fully liquid paediatric hexavalent vaccines. A time and motion study.

    abstract:BACKGROUND AND AIMS:Simplified vaccine preparation steps would save time and reduce potential immunisation errors. The aim of the study was to assess vaccine preparation time with fully-liquid hexavalent vaccine (DTaP-IPV-HB-PRP-T, Sanofi Pasteur MSD) versus non-fully liquid hexavalent vaccine that needs reconstitution...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2015.06.030

    authors: De Coster I,Fournie X,Faure C,Ziani E,Nicolas L,Soubeyrand B,Van Damme P

    更新日期:2015-07-31 00:00:00

  • Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial.

    abstract:BACKGROUND:Development of influenza vaccines that do not use embryonated eggs as the substrate for vaccine production is a high priority. We conducted this study to determine the protective efficacy a recombinant, baculovirus-expressed seasonal trivalent influenza virus hemagglutinin (rHA0) vaccine (FluBlok(®)). METHO...

    journal_title:Vaccine

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.vaccine.2011.07.128

    authors: Treanor JJ,El Sahly H,King J,Graham I,Izikson R,Kohberger R,Patriarca P,Cox M

    更新日期:2011-10-13 00:00:00

  • Combination vaccines in the South African setting.

    abstract::The number of vaccines available and included as part of the national immunization schedules, has increased significantly over the past few decades. This impacts on patient/parent compliance and creates a challenge for health care providers for implementation of schedules necessitating training and infrastructure impr...

    journal_title:Vaccine

    pub_type: 杂志文章,评审

    doi:10.1016/j.vaccine.2012.05.001

    authors: Visser A,Hoosen A

    更新日期:2012-09-07 00:00:00

  • Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.

    abstract:INTRODUCTION:Rotavirus is the most common cause of severe diarrhoea worldwide. Vietnam is situated in the region of high rotavirus infection incidence and eligible for financial support to introduce rotavirus vaccines into the Expanded Program of Immunization (EPI) from the GAVI. This study was designed to assess the c...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2011.11.052

    authors: Tu HA,Rozenbaum MH,Coyte PC,Li SC,Woerdenbag HJ,Postma MJ

    更新日期:2012-02-14 00:00:00

  • Hepatitis A vaccination coverage among adolescents (13-17 years) in the United States, 2008-2016.

    abstract:BACKGROUND:The hepatitis A (HepA) vaccine was recommended by the Advisory Committee on Immunization Practices (ACIP) incrementally from 1996 to 1999. In 2006, HepA vaccine was recommended (1) universally for children aged 12-23 months, (2) for persons who are at increased risk for infection, or (3) for any person wishi...

    journal_title:Vaccine

    pub_type: 历史文章,杂志文章

    doi:10.1016/j.vaccine.2018.01.090

    authors: Nelson NP,Yankey D,Singleton JA,Elam-Evans LD

    更新日期:2018-03-14 00:00:00

  • Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?

    abstract::B. pseudomallei is the cause of melioidosis, a serious an often fatal disease of humans and animals. The closely related bacterium B. mallei, which cases glanders, is considered to be a clonal derivative of B. pseudomallei. Both B. pseudomallei and B. mallei were evaluated by the United States and the former USSR as p...

    journal_title:Vaccine

    pub_type: 杂志文章,评审

    doi:10.1016/j.vaccine.2017.03.022

    authors: Titball RW,Burtnick MN,Bancroft GJ,Brett P

    更新日期:2017-10-20 00:00:00

  • Potency against enterotoxemia of a recombinant Clostridium perfringens type D epsilon toxoid in ruminants.

    abstract::Enterotoxemia, a disease that affects domestic ruminants, is caused mainly by the epsilon toxin from Clostridium perfringens type D. Its eradication is virtually impossible, control and prophylaxis are based on systematic vaccination of herds with epsilon toxoids that are efficient in inducing protective antibody prod...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2010.07.046

    authors: Lobato FC,Lima CG,Assis RA,Pires PS,Silva RO,Salvarani FM,Carmo AO,Contigli C,Kalapothakis E

    更新日期:2010-08-31 00:00:00

  • A pcDNA-Ehcpadh vaccine against Entamoeba histolytica elicits a protective Th1-like response in hamster liver.

    abstract::DNA vaccines are promising tools to fight parasitic diseases, including amoebiasis caused by the protozoan Entamoeba histolytica. Here we studied the immunogenicity and protective efficacy of a DNA vaccine against this parasite composed by the EhCPADH surface complex encoding genes (Ehcp112 and Ehadh112). EhCPADH is f...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2009.04.051

    authors: Martínez MB,Rodríguez MA,García-Rivera G,Sánchez T,Hernández-Pando R,Aguilar D,Orozco E

    更新日期:2009-06-24 00:00:00

  • A short report on the highlights of world-wide development of RIX4414: a North American experience comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine (RIX4414) in infants in the United Sta

    abstract::This randomized, double-blind trial conducted in the US and Canada was conducted to compare the safety and immunogenicity of two dosages of live attenuated oral monovalent G1 human rotavirus (HRV) vaccine administered orally at a 2-month interval concomitantly with routine childhood vaccines to healthy infants 5-15 we...

    journal_title:Vaccine

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.vaccine.2005.07.030

    authors: Dennehy PH,North American Human Rotavirus Vaccine Study Group.

    更新日期:2006-05-01 00:00:00

  • Porcine Reproductive and Respiratory Syndrome Virus isolates differ in their susceptibility to neutralization.

    abstract::Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) is highly heterogenic. This heterogeneity has an effect on antigenic composition of PRRSV and might create differences in sensitivity to neutralization between isolates. The sensitivity to neutralization could be an important feature of PRRSV isolates because...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2011.07.076

    authors: Martínez-Lobo FJ,Díez-Fuertes F,Simarro I,Castro JM,Prieto C

    更新日期:2011-09-16 00:00:00

  • The outer membrane protein, LamB (maltoporin), is a versatile vaccine candidate among the Vibrio species.

    abstract::Maltoporin (LamB) is a family of outer membrane proteins. There has been no report of immunological characteristics of LamB in the Vibrio species so far. In this study, lamB genes from eight Vibrio strains were cloned and sequenced. The bioinformatics analysis indicated that sequence similarities of LamB proteins were...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2013.12.035

    authors: Lun J,Xia C,Yuan C,Zhang Y,Zhong M,Huang T,Hu Z

    更新日期:2014-02-07 00:00:00

  • Polio immunity to killed vaccine: an 18-year follow-up.

    abstract::Two hundred and fifty children born in 1967 and vaccinated with killed polio vaccine in Sweden were followed for 18 years and tested for neutralizing antibodies against polio. All of them had demonstrable antibodies at the age of 18. Sixty-four children were tested in samples collected throughout the years. After a mo...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/0264-410x(90)90244-g

    authors: Böttiger M

    更新日期:1990-10-01 00:00:00

  • Cost-effectiveness of adult vaccinations: A systematic review.

    abstract:BACKGROUND:Coverage levels for many recommended adult vaccinations are low. The cost-effectiveness research literature on adult vaccinations has not been synthesized in recent years, which may contribute to low awareness of the value of adult vaccinations and to their under-utilization. We assessed research literature ...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2018.11.056

    authors: Leidner AJ,Murthy N,Chesson HW,Biggerstaff M,Stoecker C,Harris AM,Acosta A,Dooling K,Bridges CB

    更新日期:2019-01-07 00:00:00

  • Vaccination as a means of control of foot-and-mouth disease in sub-saharan Africa.

    abstract::The presence of foot-and-mouth disease (FMD) in a country is a major obstacle to the development of agriculture because of its adverse effects on livestock production and agricultural exports. The eradication of FMD in sub-saharan Africa by the implementation of slaughtering-out is impractical for various reasons, but...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/s0264-410x(97)00170-9

    authors: Hunter P

    更新日期:1998-01-01 00:00:00

  • DNA vaccination with the serine rich Entamoeba histolytica protein (SREHP) prevents amebic liver abscess in rodent models of disease.

    abstract::Amebiasis remains one of the leading parasitic causes of death worldwide. A vaccine that prevented amebic liver abscess would significantly reduce mortality from this disease. To test the feasibility of a DNA vaccine to prevent amebic liver abscess, we immunized both mice and gerbils with plasmid DNA encoding the seri...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/s0264-410x(99)00343-6

    authors: Zhang T,Stanley SL Jr

    更新日期:1999-12-10 00:00:00

  • Similar long-term vaccine efficacy of two versus three doses of HBV vaccine in early life.

    abstract::WHO currently recommends three vaccinations against hepatitis B to provide optimal protection against infection and carriage. However, immunological theory and mathematical modelling suggest that similar protection could be induced with two doses, and trials among adolescents and adults have shown comparable rates for...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2006.10.023

    authors: van der Sande MA,Mendy M,Waight P,Doherty C,McConkey SJ,Hall AJ,Whittle HC

    更新日期:2007-02-09 00:00:00

  • CD8 T cell independent immunity after single dose infection-treatment-vaccination (ITV) against Plasmodium yoelii.

    abstract::Sporozoite vaccination of both humans and rodents elicits potent anti-malarial immunity, but the dose of sporozoites and the number of immunizations required varies with vaccination approach. Here we examine the immunological basis for superior protection afforded from single-dose vaccination with virulent sporozoites...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2013.11.058

    authors: Doll KL,Butler NS,Harty JT

    更新日期:2014-01-16 00:00:00

  • A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route.

    abstract::In a phase I clinical trial, one hundred healthy young adults were randomized to receive two doses 28 days apart of an inactivated, subvirion vaccine containing 15 or 45microg of influenza A/H5N1 hemagglutinin (HA) by the intramuscular (IM) route, or 3 or 9microg of H5 HA by the intradermal(ID) route. Seventy-seven su...

    journal_title:Vaccine

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.vaccine.2009.10.152

    authors: Patel SM,Atmar RL,El Sahly HM,Cate TR,Keitel WA

    更新日期:2010-04-09 00:00:00

  • Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.

    abstract::Different subsets of dendritic cells (DC) elicit qualitatively different immune responses. In mice, two lymphoid tissue-resident subsets, CD8α(+) and CD8α(-), have been implicated in the induction of T helper 1 (Th1) or Th2 responses, respectively. Moreover, CD8α(+) DC appear to play a major role in priming CD8(+) T l...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2011.06.071

    authors: Suleman M,Galea S,Gavard F,Merillon N,Klonjkowski B,Tartour E,Richardson J

    更新日期:2011-08-11 00:00:00

  • Immunogenicity of chi4127 phoP- Salmonella enterica serovar Typhimurium in dogs.

    abstract::Salmonellae are commonly isolated from dogs. The number of dogs infected with Salmonella spp. is surprisingly high and greater than the incidence of clinical disease would suggest. Salmonellosis is common in greyhound kennels. Morbidity can approach 100% in puppies and the mortality ranges to nearly 40%. To date, ther...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/s0264-410x(01)00516-3

    authors: McVey DS,Chengappa MM,Mosier DE,Stone GG,Oberst RD,Sylte MJ,Gabbert NM,Kelly-Aehle SM,Curtiss R

    更新日期:2002-02-22 00:00:00

  • A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses.

    abstract::Since the production of influenza vaccines is complicated by the continuous variation of these viruses, it would be desirable to develop vaccines that induce cross-protective immunity against influenza virus strains that circulate in subsequent winter epidemics. We have recently demonstrated that antibodies induced af...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/s0264-410x(01)00262-6

    authors: Rimmelzwaan GF,Baars M,van Amerongen G,van Beek R,Osterhaus AD

    更新日期:2001-10-12 00:00:00

  • Cytoplasmic delivery of antigens, by Bacillus subtilis enhances Th1 responses.

    abstract::Endospores of the Gram-positive bacterium, Bacillus subtilis, have been used successfully for delivery of antigens where the immunogen is expressed on the spore surface. In this work the spore has been engineered to deliver antigens to the cytoplasm of macrophages by expressing listeriolysin O (LLO) or a derivative, L...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2008.09.024

    authors: Huang JM,La Ragione RM,Cooley WA,Todryk S,Cutting SM

    更新日期:2008-11-11 00:00:00

  • Comparison of prophylactic and therapeutic immunisation with an ErbB-2 (HER2) fusion protein and immunoglobulin V-gene repertoire analysis in a transgenic mouse model of spontaneous breast cancer.

    abstract::ErbB-2 is associated with several solid tumours of which breast cancer is the commonest cancer in women worldwide. Though anti-ErbB-2 antibody appears to play a significant role in prevention and therapy, naturally occurring anti-ErbB-2 antibody associated with the cleaved ectodomain of overexpressed ErbB-2 self antig...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2013.10.077

    authors: Mukhopadhyay A,Dyring C,Stott DI

    更新日期:2014-02-12 00:00:00

  • Factors influencing influenza vaccination uptake in an elderly, community-based sample.

    abstract::This study investigated predictors of influenza vaccination uptake since the introduction of the policy to target over 65s. Four hundred and forty-four participants completed a cross-sectional structured interview. The predictors of vaccination uptake were: having a doctor or nurse who explained why the vaccination is...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2004.12.031

    authors: Burns VE,Ring C,Carroll D

    更新日期:2005-05-20 00:00:00

  • A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC.

    abstract::Enterotoxigenic E. coli (ETEC) are an important cause of diarrhea in developing countries, especially among indigenous children and travelers. In this randomized, double-blind, placebo-controlled trial, a live, attenuated CS1/CS3 ETEC strain, PTL-003, was tested as a potential vaccine strain. Thirty-three subjects dra...

    journal_title:Vaccine

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.vaccine.2008.06.064

    authors: McKenzie R,Darsley M,Thomas N,Randall R,Carpenter C,Forbes E,Finucane M,Sack RB,Hall E,Bourgeois AL

    更新日期:2008-08-26 00:00:00

  • Changes in prevalence of influenza vaccination and strength of association of factors predicting influenza vaccination over time--results of two population-based surveys.

    abstract::Two cross-sectional population-based telephone surveys interviewed 877 and 1,103 respondents aged >or=65. When compared to the first survey, respondents of the second survey were more likely to have heard of influenza vaccination (IV) (adjusted OR=4.09), to have received IV (adjusted OR=2.04) or to have done so in the...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2007.09.047

    authors: Lau JT,Kim JH,Choi KC,Tsui HY,Yang X

    更新日期:2007-11-28 00:00:00

  • Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.

    abstract:QUESTION UNDER STUDY:To investigate the persistence of maternal IgG antibodies against Varicella-Zoster virus (VZV) in infants and young children. METHODS:Serum specimens of children aged 0-16 months who had been hospitalized in our institution between 1994 and 1999 were identified from our routine serum collection. E...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2006.01.026

    authors: Heininger U,Desgrandchamps D,Schaad UB

    更新日期:2006-04-12 00:00:00

  • Human papillomavirus vaccines: WHO position paper, October 2014-Recommendations.

    abstract::This article presents the World Health Organization's (WHO) recommendations for the use of vaccines against diseases caused by human papillomaviruses (HPV) from the WHO position paper on Human papillomavirus vaccines: WHO position paper - October 2014, recently published in the Weekly Epidemiological Record [1]. This ...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2014.12.002

    authors:

    更新日期:2015-08-26 00:00:00

  • Colinear synthesis of an antigen-specific B-cell epitope with a 'promiscuous' tetanus toxin T-cell epitope: a synthetic peptide immunocontraceptive.

    abstract::Carrier conjugation is commonly used to provide T-cell help for small, linear peptides containing antigen-specific B-cell epitopes. However, carrier conjugation is expensive, variable and often results in adverse side effects if the conjugate is administered repeatedly. To eliminate the need for carrier conjugation, w...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/s0264-410x(97)00105-9

    authors: O'Hern PA,Liang ZG,Bambra CS,Goldberg E

    更新日期:1997-11-01 00:00:00